alexa Molecular – Docking Studies of Potent Anticancer Agent
ISSN: 0974-7230

Journal of Computer Science & Systems Biology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Molecular – Docking Studies of Potent Anticancer Agent

Heena V Sanghani1*, Sunil H Ganatra2 and Rama Pande2

1Assistant Professor Sinhgad College of Engineering, Vadgaon, Pune, India

2Department of Chemistry Institute of Science, Nagpur, SOS Pt. Ravishankar Shukla University Raipur, India

*Corresponding Author:
Heena V. Sanghani
Assistant Professor in Engineering
Chemistry Sinhgad College of Engineering
Vadgaon (Bk), Pune
Tel: 91-9822369793
E-mail: [email protected]

Received Date: September 20, 2011; Accepted Date: January 25, 2012; Published Date:January 27, 2012

Citation: Sanghani HV, Ganatra SH, Pande R (2012) Molecular -Docking Studies of Potent Anticancer Agent. J Comput Sci Syst Biol 5:012-015. doi:10.4172/jcsb.1000085

Copyright: © 2012 Sanghani HV, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Cyclin dependent kinases are critical molecules that control cell cycle progression from one phase to the other. However, mutational changes in these molecules lead to the purturbed cell cycle leading to uncontrolled cellular proliferation or cell death. In humans, mutations in cyclin dependent kinase 2 (1GII) is responsible for nearly 50% of cancers. In this paper preliminary in-silico screening were performed of natural polytriterpene phytochemical that are thought to have potential to inhibit mutated 1GII. Out of the two triterpenes boswellic acid and ursolic acid, boswellic acid shows inhibition activity with 1GII. From this study we propose that boswellic acid is promising towards oral cancer than ursolic acid.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version